BR112015021297A2 - um processo para a produção de adenovírus. - Google Patents

um processo para a produção de adenovírus.

Info

Publication number
BR112015021297A2
BR112015021297A2 BR112015021297A BR112015021297A BR112015021297A2 BR 112015021297 A2 BR112015021297 A2 BR 112015021297A2 BR 112015021297 A BR112015021297 A BR 112015021297A BR 112015021297 A BR112015021297 A BR 112015021297A BR 112015021297 A2 BR112015021297 A2 BR 112015021297A2
Authority
BR
Brazil
Prior art keywords
adenovirus
production
Prior art date
Application number
BR112015021297A
Other languages
English (en)
Inventor
Robert Champion Brian
Bhatia Jeetendra
Fisher Kerry
Original Assignee
Psioxus Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psioxus Therapeutics Ltd filed Critical Psioxus Therapeutics Ltd
Publication of BR112015021297A2 publication Critical patent/BR112015021297A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • A61K35/761Adenovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10032Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10051Methods of production or purification of viral material
    • C12N2710/10052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10332Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112015021297A 2013-02-28 2014-02-28 um processo para a produção de adenovírus. BR112015021297A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361770513P 2013-02-28 2013-02-28
PCT/EP2014/053987 WO2014131898A1 (en) 2013-02-28 2014-02-28 A process for the production of adenovirus

Publications (1)

Publication Number Publication Date
BR112015021297A2 true BR112015021297A2 (pt) 2017-10-10

Family

ID=50390048

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015021297A BR112015021297A2 (pt) 2013-02-28 2014-02-28 um processo para a produção de adenovírus.

Country Status (13)

Country Link
US (1) US20160090574A1 (pt)
EP (1) EP2961417A1 (pt)
JP (1) JP2016509836A (pt)
KR (1) KR20150122674A (pt)
CN (1) CN105189739A (pt)
AU (1) AU2014222610A1 (pt)
BR (1) BR112015021297A2 (pt)
CA (1) CA2902650A1 (pt)
HK (1) HK1218507A1 (pt)
IL (1) IL240748A0 (pt)
RU (1) RU2015135473A (pt)
SG (2) SG10201706863SA (pt)
WO (1) WO2014131898A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2971008B1 (en) 2013-03-14 2018-07-25 Salk Institute for Biological Studies Oncolytic adenovirus compositions
GB201415579D0 (en) * 2014-09-03 2014-10-15 Psioxus Therapeutics Ltd A process
EP3186366A2 (en) * 2014-08-27 2017-07-05 Psioxus Therapeutics Limited A process for the production of adenovirus
CN104958324A (zh) * 2015-05-29 2015-10-07 黄波 一种溶瘤病毒制剂及其制备方法
JP7015551B2 (ja) 2016-02-23 2022-02-15 ソーク インスティテュート フォー バイオロジカル スタディーズ ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現
JP7054527B2 (ja) 2016-02-23 2022-04-14 ソーク インスティテュート フォー バイオロジカル スタディーズ アデノウイルスの複製動態を測定するための高スループットアッセイ
CA3045892A1 (en) 2016-12-12 2018-06-21 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
PT3630143T (pt) * 2017-06-01 2023-08-29 Akamis Bio Ltd Vírus oncolítico e método
GB201909081D0 (en) * 2019-06-25 2019-08-07 Psioxus Therapeutics Ltd Method
CN110894494B (zh) * 2019-11-22 2022-09-27 广西梧州制药(集团)股份有限公司 一种大规模高密度悬浮培养293细胞高产腺病毒的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ438398A3 (cs) * 1996-07-01 1999-03-17 Rhone-Poulenc Rorer S. A. Způsob přípravy rekombinantních adenovirů
EP1718738A2 (en) * 2004-02-23 2006-11-08 Crucell Holland B.V. Virus purification methods
WO2005118825A2 (en) * 2004-05-26 2005-12-15 Schering Aktiengesellschaft Chimeric adenoviruses for use in cancer treatment
CA2673520A1 (en) 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Generation of oncolytic adenoviruses and uses thereof
CN101235365A (zh) * 2007-01-31 2008-08-06 深圳市清华源兴生物医药科技有限公司 一种高效生产腺病毒的方法
JP5465331B2 (ja) 2009-10-15 2014-04-09 クルセル ホランド ベー ヴェー 高細胞密度の培養物からのアデノウイルスの精製方法

Also Published As

Publication number Publication date
WO2014131898A1 (en) 2014-09-04
SG11201506624SA (en) 2015-09-29
CN105189739A (zh) 2015-12-23
KR20150122674A (ko) 2015-11-02
JP2016509836A (ja) 2016-04-04
IL240748A0 (en) 2015-10-29
CA2902650A1 (en) 2014-09-04
SG10201706863SA (en) 2017-10-30
AU2014222610A1 (en) 2015-10-15
HK1218507A1 (zh) 2017-02-24
EP2961417A1 (en) 2016-01-06
RU2015135473A (ru) 2017-03-31
US20160090574A1 (en) 2016-03-31

Similar Documents

Publication Publication Date Title
CL2016001080A1 (es) Benzamidas sustituidas para tratamiento de artrópodos.
FI20135292A (fi) Menetelmä kartongin valmistamiseksi
BR112015023670A2 (pt) processo para preparar um composto
BR112014026802A2 (pt) processo para a preparação de um a, \omega-cn diol.
BR112016014715A2 (pt) Processo para produzir um material de nanocelulose e processo para produzir um material de nanocelulose hidrofóbico
BR112015021297A2 (pt) um processo para a produção de adenovírus.
BR112016013492A2 (pt) processo para a preparação de ácidos alcanossulfônicos.
BR112014030071A2 (pt) processo para a fabricação de um vapor de dafd, e, composição
BR112015003101A2 (pt) processo para a preparação de um composto.
BR112014026796A2 (pt) processo
BR112016010223A2 (pt) processo para a preparação de iopamidol.
BR112015002912A2 (pt) processo para a produção de benzoxazinonas
BR112016018581A2 (pt) Processo para a fabricação de derivados de sulfamida pirimidina
BR112016013624A2 (pt) processo para a produção de gás de síntese
BR112014028570A2 (pt) processo para fabricação de compostos de ciclopentilpirimidina hidroxilada.
DK3016976T3 (da) Proces
BR112017010466A2 (pt) processo para a produção de metildiclorofosfano
BR112018002930A2 (pt) processo para preparação de um composto.
BR112014026799A2 (pt) método para a produção de um açúcar líquido.
BR112016026212A2 (pt) Processo para preparar cianidrina contendo fósforo
BR112016000315A2 (pt) processo para produção de um compósito bio-elastômero hidrofóbico e compósito bio-elastômero
BR112016025076A2 (pt) processo para a preparação de ciclosserinas substituídas
BR112016019608A2 (pt) processo para purificação de polissacarídeos de men-c
BR112015020373A2 (pt) processo para produção de um poliuretano, poliuretano e uso de um poliuretano.
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2503 DE 26-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI